SCHEMBL5099673

SCHEMBL5099673

OC(CCCCCCCBr)(c1ccc(F)cc1)c1ccc(F)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.42
CYP2D6 P10635 2/20 0.42
CYP2C9 P11712 2/20 0.42
CYP2C19 P33261 2/20 0.42
SIGMAR1 Q99720 1/20 0.40
BCL2 P10415 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.37
HTT P42858 2/20 0.37
KMT2A Q03164 2/20 0.37
GAA P10253 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
LMNA P02545 1/20 0.37
PTPN1 P18031 1/20 0.37
USP2 O75604 1/20 0.36
RAB9A P51151 1/20 0.36
HDAC6 Q9UBN7 1/20 0.35
CYP19A1 P11511 1/20 0.34
CHRM4 P08173 4/20 0.34
CHRM5 P08912 4/20 0.34
CHRM3 P20309 4/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7813623 0.98 CYP3A4 (0.43) CYP3A4CYP2D6CYP2C9CYP2C19SIGMAR1
SCHEMBL23880652 0.81 CYP2D6 (0.44) CYP3A4CYP2D6CYP2C9CYP2C19SIGMAR1
SCHEMBL5091772 0.81 SIGMAR1 (0.59) CYP2D6SIGMAR1BCL2LMNACHRM4
SCHEMBL5093688 0.81 SIGMAR1 (0.59) CYP2D6SIGMAR1BCL2LMNACHRM4
SCHEMBL5089212 0.79 SIGMAR1 (0.61) CYP2D6SIGMAR1BCL2LMNACHRM4
SCHEMBL11836940 0.77 CYP3A4 (0.44) CYP3A4CYP2D6CYP2C9CYP2C19SIGMAR1
SCHEMBL11024439 0.76 CYP3A4 (0.50) CYP3A4CYP2D6CYP2C9CYP2C19L3MBTL1
SCHEMBL11868000 0.71 BCL2 (0.49) CYP2D6SIGMAR1BCL2L3MBTL1HTT
SCHEMBL6352845 0.71 SIRT2 (0.33) CYP3A4CYP2D6CYP2C9CYP2C19PTPN1
SCHEMBL3885050 0.69 CYP3A4 (0.52) CYP3A4CYP2D6CYP2C9CYP2C19L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7320993-B1 Aryl-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic useful as cytostatic and immuosuppressive agents ASTELLAS DEUTSCHLAND GMBH (DE) 2008-01-22 US disclosed
EP-1042291-B1 ARYL-SUBSTITUTED PYRIDYLALKANE, ALKENE, AND ALKINE CARBOXAMIDES USEFUL AS CYTOSTATIC AND IMMUNOSUPPRESSIVE AGENTS KLINGE CO CHEM PHARM FAB (DE) 2005-07-13 EP disclosed
EP-1042291-A1 ARYL-SUBSTITUTED PYRIDYLALKANE, ALKENE, AND ALKINE CARBOXAMIDES USEFUL AS CYTOSTATIC AND IMMUNOSUPPRESSIVE AGENTS Klinge Pharma GmbH (DE) 2000-10-11 EP disclosed
WO-1999031064-A1 ARYL-SUBSTITUTED PYRIDYLALKANE, ALKENE, AND ALKINE CARBOXAMIDES USEFUL AS CYTOSTATIC AND IMMUNOSUPPRESSIVE AGENTS KLINGE PHARMA GMBH (DE) 1999-06-24 WO disclosed